secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001493152-23-045033
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics reports 2023 annual meeting voting results; two Class II directors elected
--------------------------------------------------------------------------------

- Robert B. Stein, MD, PhD elected with 974,293 votes for, 56,765 withheld; Jennifer Buell, PhD elected with 963,089 for, 67,969 withheld.
- Ratification of MaloneBailey LLP as auditor passed with 2,324,009 for, 9,482 against, 2,451 abstain.
- Directors Stein and Buell will serve Class II terms until 2026 annual meeting; board composition updated.
- Total shares present at meeting: 2,336,032 out of 4,330,959 entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315223045033/0001493152-23-045033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315223045033/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer